Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

Helena Earl; Louise Hiller; Anne-laure Vallier; Shrushma Loi; Karen Mcadam; Luke Hughes-davies; Daniel Rea; Donna Howe; Kerry Raynes; Helen B Higgins; Maggie Wilcox; Chris Plummer; Betania Mahler-araujo; Elena Provenzano; Anita Chhabra; Sophie Gasson; Claire Balmer; Jean E Abraham; Carlos Caldas; Peter Hall; Bethany Shinkins; Christopher Mccabe; Claire Hulme; David Miles; Andrew M Wardley; David A Cameron; Janet A Dunn

doi:10.3310/hta24400

Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

Helena Earl, Louise Hiller, Anne-laure Vallier, Shrushma Loi, Karen Mcadam, Luke Hughes-davies, Daniel Rea, Donna Howe, Kerry Raynes, Helen B Higgins, Maggie Wilcox, Chris Plummer, Betania Mahler-araujo, Elena Provenzano, Anita Chhabra, Sophie Gasson, Claire Balmer, Jean E Abraham, Carlos Caldas, Peter HallBethany Shinkins, Christopher Mccabe, Claire Hulme, David Miles, Andrew M Wardley, David A Cameron, Janet A Dunn

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-190
Journal	Health Technology Assessment
Volume	24
Issue number	40
DOIs	https://doi.org/10.3310/hta24400
Publication status	Published - 2 Sept 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3310/hta24400

https://www.journalslibrary.nihr.ac.uk/hta/hta24400

Cite this

Earl, H., Hiller, L., Vallier, A., Loi, S., Mcadam, K., Hughes-davies, L., Rea, D., Howe, D., Raynes, K., Higgins, H. B., Wilcox, M., Plummer, C., Mahler-araujo, B., Provenzano, E., Chhabra, A., Gasson, S., Balmer, C., Abraham, J. E., Caldas, C., ... Dunn, J. A. (2020). Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT. Health Technology Assessment, 24(40), 1-190. https://doi.org/10.3310/hta24400

@article{0409db8aff9549e0b155d2e5c9bc1192,

title = "Six versus 12 months{\textquoteright} adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT",

author = "Helena Earl and Louise Hiller and Anne-laure Vallier and Shrushma Loi and Karen Mcadam and Luke Hughes-davies and Daniel Rea and Donna Howe and Kerry Raynes and Higgins, {Helen B} and Maggie Wilcox and Chris Plummer and Betania Mahler-araujo and Elena Provenzano and Anita Chhabra and Sophie Gasson and Claire Balmer and Abraham, {Jean E} and Carlos Caldas and Peter Hall and Bethany Shinkins and Christopher Mccabe and Claire Hulme and David Miles and Wardley, {Andrew M} and Cameron, {David A} and Dunn, {Janet A}",

year = "2020",

month = sep,

day = "2",

doi = "10.3310/hta24400",

language = "English",

volume = "24",

pages = "1--190",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Health Technology Assessment Programme",

number = "40",

}

Earl, H, Hiller, L, Vallier, A, Loi, S, Mcadam, K, Hughes-davies, L, Rea, D, Howe, D, Raynes, K, Higgins, HB, Wilcox, M, Plummer, C, Mahler-araujo, B, Provenzano, E, Chhabra, A, Gasson, S, Balmer, C, Abraham, JE, Caldas, C, Hall, P, Shinkins, B, Mccabe, C, Hulme, C, Miles, D, Wardley, AM, Cameron, DA & Dunn, JA 2020, 'Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT', Health Technology Assessment, vol. 24, no. 40, pp. 1-190. https://doi.org/10.3310/hta24400

TY - JOUR

T1 - Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

AU - Earl, Helena

AU - Hiller, Louise

AU - Vallier, Anne-laure

AU - Loi, Shrushma

AU - Mcadam, Karen

AU - Hughes-davies, Luke

AU - Rea, Daniel

AU - Howe, Donna

AU - Raynes, Kerry

AU - Higgins, Helen B

AU - Wilcox, Maggie

AU - Plummer, Chris

AU - Mahler-araujo, Betania

AU - Provenzano, Elena

AU - Chhabra, Anita

AU - Gasson, Sophie

AU - Balmer, Claire

AU - Abraham, Jean E

AU - Caldas, Carlos

AU - Hall, Peter

AU - Shinkins, Bethany

AU - Mccabe, Christopher

AU - Hulme, Claire

AU - Miles, David

AU - Wardley, Andrew M

AU - Cameron, David A

AU - Dunn, Janet A

PY - 2020/9/2

Y1 - 2020/9/2

UR - http://www.scopus.com/inward/record.url?scp=85090491908&partnerID=8YFLogxK

U2 - 10.3310/hta24400

DO - 10.3310/hta24400

M3 - Article

SN - 1366-5278

VL - 24

SP - 1

EP - 190

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 40

ER -